Lista de obras -

A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation

artículo científico publicado en 2015

A case with recovery of response to tolvaptan associated with remission of acute kidney injury and increased urine osmolality

artículo científico publicado en 2013

An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension

artículo científico publicado en 2015

Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation

artículo científico publicado en 2014

Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device

artículo científico publicado en 2012

Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device

artículo científico publicado en 2012

Correction of hyponatremia by tolvaptan before left ventricular assist device implantation

artículo científico publicado en 2012

Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients

artículo científico publicado en 2013

Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential “thromborestenosis” phenomenon

artículo científico publicado el 1 de agosto de 2010

Introns in protein-coding genes in Archaea

artículo científico publicado en 2002

Is Achieved Heart Rate a Surrogate Maker during Titration of Beta-blocker in Heart Failure with Atrial Fibrillation?

artículo científico publicado en 2013

Is the internal jugular vein or femoral vein a better approach site for endomyocardial biopsy in heart transplant recipients?

artículo científico publicado en 2014

Late rejection occurred in recipients who experienced acute cellular rejection within the first year after heart transplantation

artículo científico publicado en 2015

Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device

artículo científico publicado en 2014

Low Blood Pressure, Low Serum Cholesterol and Anemia Predict Early Necessity of Ventricular Assist Device Implantation in Patients With Advanced Heart Failure at the Time of Referral From Non-Ventricular Assist Device Institutes

artículo científico publicado en 2014

Low blood pressure, low serum cholesterol and anemia predict early necessity of ventricular assist device implantation in patients with advanced heart failure at the time of referral from non-ventricular assist device institutes

artículo científico publicado en 2014

Low cardiac output stimulates vasopressin release in patients with stage d heart failure

artículo científico publicado en 2014

Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment

artículo científico publicado en 2014

Novel Scoring System to Predict Ineligibility for Bridge to Implantable Left Ventricular Assist Device as Destination Therapy Before Extracorporeal Ventricular Assist Device Implantation - For the Coming Era of Destination Therapy in Japan

artículo científico publicado en 2015

Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device

artículo científico publicado en 2012

Novel scoring system using cardiopulmonary exercise testing predicts prognosis in heart failure patients receiving guideline-directed medical therapy

artículo científico publicado en 2015

Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device

artículo científico publicado en 2014

Opening of native aortic valve accomplished after left ventricular assist device implantation in patients with insufficient preoperative Beta-blocker treatment

artículo científico publicado en 2015

Parasympathetic reinnervation accompanied by improved post-exercise heart rate recovery and quality of life in heart transplant recipients

artículo científico publicado en 2015

Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy

artículo científico publicado en 2015

Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery

artículo científico publicado en 2013

Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device

artículo científico publicado en 2012

Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device

artículo científico publicado en 2015

Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support

artículo científico publicado en 2015

Recipients with shorter cardiopulmonary bypass time achieve improvement of parasympathetic reinnervation within 6 months after heart transplantation

artículo científico publicado en 2014

Status 2 patients had poor prognosis without mechanical circulatory support

artículo científico

Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation ⬇️

artículo científico publicado el 1 de enero de 2013

Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation

artículo científico publicado en 2013

Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension

artículo científico publicado en 2015

The potential of RF backscattered IVUS data and multidetector-row computed tomography images for tissue characterization of human coronary atherosclerotic plaques

artículo científico publicado en 2009

Tolvaptan can improve clinical course in responders.

artículo científico publicado en 2013

Trend of clinical outcome and surrogate markers during titration of β-blocker in heart failure patients with reduced ejection fraction: relevance of achieved heart rate and β-blocker dose

artículo científico publicado en 2012

Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients

artículo científico publicado en 2013

Lista de obras de

A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation

A case with recovery of response to tolvaptan associated with remission of acute kidney injury and increased urine osmolality

An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension

Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation

Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device

Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device

Correction of hyponatremia by tolvaptan before left ventricular assist device implantation

Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients

Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential “thromborestenosis” phenomenon

Introns in protein-coding genes in Archaea

Is Achieved Heart Rate a Surrogate Maker during Titration of Beta-blocker in Heart Failure with Atrial Fibrillation?

Is the internal jugular vein or femoral vein a better approach site for endomyocardial biopsy in heart transplant recipients?

Late rejection occurred in recipients who experienced acute cellular rejection within the first year after heart transplantation

Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device

Low Blood Pressure, Low Serum Cholesterol and Anemia Predict Early Necessity of Ventricular Assist Device Implantation in Patients With Advanced Heart Failure at the Time of Referral From Non-Ventricular Assist Device Institutes

Low blood pressure, low serum cholesterol and anemia predict early necessity of ventricular assist device implantation in patients with advanced heart failure at the time of referral from non-ventricular assist device institutes

Low cardiac output stimulates vasopressin release in patients with stage d heart failure

Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment

Novel Scoring System to Predict Ineligibility for Bridge to Implantable Left Ventricular Assist Device as Destination Therapy Before Extracorporeal Ventricular Assist Device Implantation - For the Coming Era of Destination Therapy in Japan

Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device

Novel scoring system using cardiopulmonary exercise testing predicts prognosis in heart failure patients receiving guideline-directed medical therapy

Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device

Opening of native aortic valve accomplished after left ventricular assist device implantation in patients with insufficient preoperative Beta-blocker treatment

Parasympathetic reinnervation accompanied by improved post-exercise heart rate recovery and quality of life in heart transplant recipients

Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy

Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery

Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device

Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device

Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support

Recipients with shorter cardiopulmonary bypass time achieve improvement of parasympathetic reinnervation within 6 months after heart transplantation

Status 2 patients had poor prognosis without mechanical circulatory support

Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation ⬇️

Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation

Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension

The potential of RF backscattered IVUS data and multidetector-row computed tomography images for tissue characterization of human coronary atherosclerotic plaques

Tolvaptan can improve clinical course in responders.

Trend of clinical outcome and surrogate markers during titration of β-blocker in heart failure patients with reduced ejection fraction: relevance of achieved heart rate and β-blocker dose

Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients